Results for Fourth Quarter and Financial Year ended March 31, 2026

Profit growth above 25%Revenue growth above 20%Exceptional itemResults View source PDF Explain this filing

MAXHEALTH · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-6.4%Reaction day

₹1093.15

prior close

₹1068.25

announcement price

After-mkt

timing

Nifty 100market · index membership as recorded later (tracked since Jun 2026)+0.3%-6.7% vs market

Hospital peers, median of 24sector+0.2%-6.7% vs sector

On the reaction day the stock moved 6.7 pts less than Nifty 100 and 6.7 pts less than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-2.7

10m

-3.9

15m

-4.7

30m

-4.6

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-6.4+0.3-6.7+0.2-6.7

Next day

-8.5+1.6-10.1+0.6-9.1

-9.2+1.3-10.4+0.4-9.6

-9.0+1.5-10.5-0.5-8.4

-11.7+0.0-11.8+0.6-12.4

-13.7-0.8-12.9-0.2-13.5

-11.7-0.8-11.0+0.7-12.4

15d

-5.8+1.3-7.0-0.2-5.5

-0.0+2.5-2.5+3.0-3.0

-1.1+1.9-3.0+2.7-3.8

-9.4+3.1-12.5+5.6-15.0

UpDownMarket · Nifty 100Sector · Hospital peers, median of 24Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Max Healthcare reported strong FY26 results with consolidated revenue growing 19.1% year-over-year to ₹8,37,345 lakhs. Profit after tax surged 34.1% to ₹1,44,241 lakhs, driven by the merger of Crosslay Remedies with Jaypee Healthcare (completed December 2025) which resulted in a cumulative tax benefit of ₹14,148 lakhs. EPS improved to ₹14.83 from ₹11.07. Exceptional items of ₹4,824 lakhs include ₹3,390 lakhs impact from new Labour Codes. The company also completed acquisition of 58.28% stake in Kalinga Hospitals (May 2026) for ₹29,797 lakhs and approved construction of a new 712-bed hospital in Lucknow. Auditors issued an unmodified (clean) opinion.

Likely market impact

The 34% PAT growth significantly exceeds the 25% benchmark and signals strong operational performance. However, expansion investments (Lucknow hospital, Kalinga acquisition) and higher labour costs may compress margins near-term. The clean audit opinion removes key risks. Shareholders can expect dividend of ₹2 per share subject to AGM approval.